1HSG
CRYSTAL STRUCTURE AT 1.9 ANGSTROMS RESOLUTION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) II PROTEASE COMPLEXED WITH L-735,524, AN ORALLY BIOAVAILABLE INHIBITOR OF THE HIV PROTEASES
Experimental procedure
Spacegroup name | P 21 21 2 |
Unit cell lengths | 59.570, 87.070, 46.710 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | ? - 2.000 |
R-factor | 0.166 |
Rwork | 0.166 |
RMSD bond length | 0.017 |
RMSD bond angle | 1.900 |
Phasing software | X-PLOR |
Refinement software | X-PLOR |
Data quality characteristics
Overall | |
High resolution limit [Å] | 1.900 * |
Rmerge | 0.061 * |
Total number of observations | 58752 * |
Number of reflections | 25153 * |
Completeness [%] | 80.0 * |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | Vapor diffusion, hanging drop * | 7.5 * | 4 * |
Crystallization Reagents in Literatures
ID | crystal ID | solution | reagent name | concentration (unit) | details |
1 | 1 | reservoir | HEPES | 0.1 (M) | |
2 | 1 | reservoir | PEG4000 | 4 (%) | |
3 | 1 | reservoir | butanol | 4 (%) |